207 related articles for article (PubMed ID: 37368400)
1. Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With Chemoradiotherapy.
Ma SJ; Khan M; Chatterjee U; Santhosh S; Hashmi M; Gill J; Yu B; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Yu H; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky E; Singh AK
JAMA Netw Open; 2023 Jun; 6(6):e2320513. PubMed ID: 37368400
[TBL] [Abstract][Full Text] [Related]
2. Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer.
Ma SJ; Yu H; Yu B; Waldman O; Khan M; Chatterjee U; Santhosh S; Gill J; Iovoli AJ; Farrugia M; Shevorykin A; Carl E; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Sheffer C; Warren GW; Singh AK
JAMA Netw Open; 2022 Dec; 5(12):e2245818. PubMed ID: 36480200
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck Cancer.
Ma SJ; Yu H; Khan M; Gill J; Santhosh S; Chatterjee U; Iovoli A; Farrugia M; Mohammadpour H; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Hicks WL; Platek ME; Seshadri M; Ray AD; Repasky E; Singh AK
JAMA Netw Open; 2022 Apr; 5(4):e227567. PubMed ID: 35426920
[TBL] [Abstract][Full Text] [Related]
5. Association of Obesity or Weight Change With Coronary Heart Disease Among Young Adults in South Korea.
Choi S; Kim K; Kim SM; Lee G; Jeong SM; Park SY; Kim YY; Son JS; Yun JM; Park SM
JAMA Intern Med; 2018 Aug; 178(8):1060-1068. PubMed ID: 29913019
[TBL] [Abstract][Full Text] [Related]
6. Can adaptive threshold-based metabolic tumor volume (MTV) and lean body mass corrected standard uptake value (SUL) predict prognosis in head and neck cancer patients treated with definitive radiotherapy/chemoradiotherapy?
Akagunduz OO; Savas R; Yalman D; Kocacelebi K; Esassolak M
Nucl Med Biol; 2015 Nov; 42(11):899-904. PubMed ID: 26275933
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
[TBL] [Abstract][Full Text] [Related]
8. Impact of obesity on outcomes for patients with head and neck cancer.
Hicks DF; Bakst R; Doucette J; Kann BH; Miles B; Genden E; Misiukiewicz K; Posner M; Gupta V
Oral Oncol; 2018 Aug; 83():11-17. PubMed ID: 30098765
[TBL] [Abstract][Full Text] [Related]
9. Effect of postradiotherapy neck dissection on nonregional disease sites.
Ranck MC; Abundo R; Jefferson G; Kolokythas A; Wenig BL; Weichselbaum RR; Spiotto MT
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):12-21. PubMed ID: 24263403
[TBL] [Abstract][Full Text] [Related]
10. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
11. Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
Katsuura T; Kitajima K; Fujiwara M; Terada T; Uwa N; Noguchi K; Doi H; Tamaki Y; Yoshida R; Tsuchitani T; Fujita M; Yamakado K
Ann Nucl Med; 2018 Aug; 32(7):453-462. PubMed ID: 29858797
[TBL] [Abstract][Full Text] [Related]
12. BMI trajectories and risk of overall and grade-specific prostate cancer: An observational cohort study among men seen for prostatic conditions.
Wang K; Chen X; Gerke TA; Bird VY; Ghayee HK; Prosperi M
Cancer Med; 2018 Oct; 7(10):5272-5280. PubMed ID: 30207080
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
Li D; Morris JS; Liu J; Hassan MM; Day RS; Bondy ML; Abbruzzese JL
JAMA; 2009 Jun; 301(24):2553-62. PubMed ID: 19549972
[TBL] [Abstract][Full Text] [Related]
14. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer.
Walter V; Jansen L; Hoffmeister M; Ulrich A; Roth W; Bläker H; Chang-Claude J; Brenner H
Am J Clin Nutr; 2016 Oct; 104(4):1110-1120. PubMed ID: 27581471
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Body Mass Index in Early and Middle Adulthood and Estimated Risk of Gastrointestinal Cancer.
Loomans-Kropp HA; Umar A
JAMA Netw Open; 2023 May; 6(5):e2310002. PubMed ID: 37163267
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
Lee A; Woods R; Mahfouz A; Kitpanit S; Cartano O; Mohamed N; Youssef I; Marqueen K; Sine K; Mah D; Neal B; Zakeri K; Kang JJ; Riaz N; Yu Y; McBride SM; Chen LD; Tsai CJ; Gelblum DY; Press RH; Michel LS; Sherman EJ; Pfister D; Dunn LA; Ho AL; Fetten J; Wong RJ; Boyle JO; Singh B; Cracchiolo JR; Ganly I; Cohen MA; Lee NY
JAMA Netw Open; 2023 Jan; 6(1):e2250607. PubMed ID: 36689229
[TBL] [Abstract][Full Text] [Related]
18. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
19. Clinical Prognostic Factors for Patients With Esophageal Cancer Treated With Definitive Chemoradiotherapy.
Favareto SL; Sousa CF; Pinto PJ; Ramos H; Chen MJ; Castro DG; Silva ML; Gondim G; Pellizzon ACA; Fogaroli RC
Cureus; 2021 Oct; 13(10):e18894. PubMed ID: 34820218
[TBL] [Abstract][Full Text] [Related]
20. The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancer.
Kicken MP; Kilinc HD; Cramer-van der Welle CM; Houterman S; van den Borne BEEM; Smit AAJ; van de Garde EMW; Deenen MJ;
Cancer Treat Res Commun; 2023; 34():100676. PubMed ID: 36592497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]